RX-RA 69

structure given in first source

Also Known As:

8-benzylthio-4-morpholino-2-piperazinylpyrimido(5,4-d)pyrimidine; Pyrimido(5,4-d)pyrimidine, 4-(4-morpholinyl)-8-((phenylmethyl)thio)-2-(1-piperazinyl)-

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 510
    - RX-RA 69: 1

Related Diseases

1.	Lewis Lung Carcinoma 01/01/1982 - "Antimetastatic action of RX-RA 69, a new potent PDE-inhibitor in the Lewis lung carcinoma of the mouse."
2.	Neoplasms (Cancer) 01/01/1982 - "In the spontaneous model an inhibition of metastases formation by 10-20 mg/kg RX-RA 69 starting from the fourth day after tumor cell implantation was found in four independent experiments. " 01/01/1982 - "RX-RA 69, a pyrimido-pyrimidine derivative, is a new potent PDA-inhibitor which inhibits tumor cell induced platelet aggregation in vitro. "
3.	Neoplasm Metastasis (Metastasis) 01/01/1982 - "In the spontaneous model an inhibition of metastases formation by 10-20 mg/kg RX-RA 69 starting from the fourth day after tumor cell implantation was found in four independent experiments. "

Related Drugs and Biologics

1.	pyrimidine